Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities (2013 - 2020)

Armata Pharmaceuticals (ARMP) has 8 years of Total Non-Current Liabilities data on file, last reported at $20.7 million in Q4 2020.

• For the quarter ending Q4 2020, Total Non-Current Liabilities rose 117.21% year-over-year to $20.7 million; the trailing twelve-month figure through Dec 2020 stood at $20.7 million (up 117.21% YoY), and the FY2020 full-year result was $20.7 million, up 117.21% from the prior year.
• Total Non-Current Liabilities grew to $20.7 million in Q4 2020, from $9.5 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $20.7 million in Q4 2020 to a low of $2.9 million in Q1 2018.
• A 5-year average of $6.6 million and a median of $5.7 million in 2018 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities sank 76.66% in 2016 and surged 284.42% in 2019, its largest moves.
• Tracing ARMP's Total Non-Current Liabilities over 5 years: stood at $6.0 million in 2016, then tumbled by 47.97% to $3.1 million in 2017, then jumped by 84.08% to $5.7 million in 2018, then surged by 65.87% to $9.5 million in 2019, then surged by 117.21% to $20.7 million in 2020.
• Business Quant data shows ARMP's Total Non-Current Liabilities at $20.7 million in Q4 2020, $9.5 million in Q4 2019, and $9.9 million in Q3 2019.